Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms - Sara Hestehave; Roxana Florea; Samuel Singleton; Alex J. H. Fedorec; Sara Caxaria; Oakley B. Morgan; Katharina Tatjana Kopp; Laurence A. Brown; Tim Heymann; Shafaq Sikandar; Felix Hausch; Stuart N. Peirson; et al. (Proceedings of the National Academy of Sciences, 2025)